Virtual conference call about HTC strategic initiatives in life science and nanotechnology. Methodist Research Institute and MD Anderson develop translational nanomedicine technologies. Both organizations are represented on the Scientific Advisory Board. We developed the Scientific Advisory Board to address Academic-Industrial Biotechnology Manufacturing and Processing Standardizations to catalyze the medical-based engineering and translation through the FDA and into commercial sectors.   

The SAB will bring a specific focus to academia, industry and government agencies to engage the various communities locally, nationally and globally to discover a specific Houston roadmap for this initiative. This would be an excellent networking and leadership opportunity to ensure products are actually market ready when they enter your spectrum of the market space. Moreover, it’s important we ensure these technologies becomes an economic resource for the Houston economy and employment rates.